BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 38496354)

  • 1. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
    Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
    Front Immunol; 2022; 13():933973. PubMed ID: 36045691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of glycosyltransferase-related genes signature and integrative analyses in patients with ovarian cancer.
    Zhang Y; Zhou T; Tang Q; Feng B; Liang Y
    Am J Clin Exp Immunol; 2024; 13(1):12-25. PubMed ID: 38496354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer.
    Xu X; Wu Y; Jia G; Zhu Q; Li D; Xie K
    J Ovarian Res; 2023 Jan; 16(1):5. PubMed ID: 36611197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer.
    Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P
    J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a ferroptosis- and oxidative stress-associated gene signature for prognostic stratification of ovarian cancer.
    Li S; Cao T; Wu T; Xu J; Shen C; Hou S; Wu Y
    Am J Transl Res; 2023; 15(4):2645-2655. PubMed ID: 37193145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Characterization of Cuproptosis-related lncRNAs: Defining Molecular Subtypes and a Prognostic Signature of Ovarian Cancer.
    Li N; Yu K; Huang D; Li S; Zeng D; Li J; Fan L
    Biol Trace Elem Res; 2024 Apr; 202(4):1428-1445. PubMed ID: 37528285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biology of VSIG4: Implications for the treatment of immune-mediated inflammatory diseases and cancer.
    Liu B; Cheng L; Gao H; Zhang J; Dong Y; Gao W; Yuan S; Gong T; Huang W
    Cancer Lett; 2023 Jan; 553():215996. PubMed ID: 36343787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Biomarkers for the Early Detection of Ovarian Cancer.
    Zhang R; Siu MKY; Ngan HYS; Chan KKL
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrative pan-cancer analysis of the molecular and biological features of glycosyltransferases.
    Li Y; Lin Y; Aye L; Dong L; Zhang C; Chen F; Liu Y; Fan J; Gao Q; Lu H; Lu C; Zhang S
    Clin Transl Med; 2022 Jul; 12(7):e872. PubMed ID: 35808804
    [No Abstract]   [Full Text] [Related]  

  • 11. Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer.
    Xu J; Fang Y; Chen K; Li S; Tang S; Ren Y; Cen Y; Fei W; Zhang B; Shen Y; Lu W
    Clin Cancer Res; 2022 Aug; 28(16):3590-3602. PubMed ID: 35675036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMEM181: a key mediator of cytolethal distending toxin required for Wnt signaling activity.
    Zhang J; Yang X; Zhu S; Dai ZM; Zhu XJ
    J Genet Genomics; 2023 Jan; 50(1):54-57. PubMed ID: 35577237
    [No Abstract]   [Full Text] [Related]  

  • 13. Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer.
    Liang L; Li J; Yu J; Liu J; Xiu L; Zeng J; Wang T; Li N; Wu L
    Cancer Cell Int; 2022 Mar; 22(1):118. PubMed ID: 35292033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques.
    Haga Y; Ueda K
    Glycoconj J; 2022 Apr; 39(2):303-313. PubMed ID: 35156159
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.